Escuche esta historia
--:--
2:16
Russia to release Sputnik nasal vaccine against Covid-19
Russia will commercialize in 2022, the nasal vaccine that will prevent and provide protection against omicron variation.
The Government of Russia assured that it will be on the market in the first quarter of 2022, and detailed that the Gamaleya Center are the manufacturers of the drug. This information was also published by the Gamaleya center via its Twitter account.
This nasal vaccine created by Russia will be especially against the omicron variation, "deeply" infectious, since it will not only ensure against contamination, but also prevent transmission.
At first, there was talk of targeting this new immunization in young people between 8 and 12 years old.
Russian President Vladimir Putin pointed out that the two-part Sputnik V anticovid immunization is exceptionally potent against the omicron variant. Likewise, he assured that its effectiveness is around 90%.
Nasal immunization is the third drug against Covid-19 created by Russia
To adapt to the Covid-19 pandemic, Russia has produced three drugs, including the Sputnik nasal vaccine, which will be available in 2022.
Russian scientists from mid-2021 reported that they were working on studies to be able to carry out the idea of nasal inoculation. Currently, this is the only one of its kind.
However, other countries are expected to begin research for a similar drug.
For more than 70 countries, the two-dose Sputnik V vaccine is the only one that has been endorsed for use, so far. However, 21 states have endorsed Sputnik Light, which has a single dose, and has been available since December 2021.
Regarding the omicron variant, the creators of the Russian antibody have argued that until further notice there is no compelling reason to promote another drug to combat it.
The head of diplomacy, Sergey Lavrov, is still holding talks with the director general of the World Health Organization (WHO), Tedros Adhanom, to investigate the possible approval of both Russian antibodies.
This confirms that at the moment, neither of the two Russian vaccines have been approved by the WHO.
